. Author manuscript; available in PMC: 2010 Dec 1.

Published in final edited form as: J Biomed Inform. 2009 Jun 16;42(6):990–1003. doi: 10.1016/j.jbi.2009.05.010

Table 5.

The seven validation set non-interactions that we used to characterize the DIKB’s prediction performance.

Pair	Source
diltiazem - pravastatin*	[41]
erythromycin - rosuvastatin*	[8]
fluconazole - 14-OH-clarithromycin*	[39]
fluconazole - pravastatin*	[47]
fluconazole - rosuvastatin*	[13]
itraconazole - fluvastatin*	[10]
nefazodone - pravastatin*	[36]

Asterisks indicate which drug or drug metabolite should not be affected by a metabolic inhibition interaction involving the other drug in the pair.